Mimedx (MDXG) Accumulated Expenses (2011 - 2026)

Mimedx's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $14.5 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 22.51% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (down 22.51% YoY), while the FY2025 annual figure was $31.1 million, up 244.71% from the prior year.
• Accumulated Expenses came in at $14.5 million for Q1 2026 at Mimedx, down from $31.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $31.1 million in Q4 2025 to a low of $8.4 million in Q3 2024.
• A 5-year average of $17.3 million and a median of $17.9 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses slumped 68.01% in 2022 and jumped 244.71% in 2025, its largest moves.
• Mimedx's Accumulated Expenses stood at $20.9 million in 2022, then advanced by 7.18% to $22.4 million in 2023, then tumbled by 59.68% to $9.0 million in 2024, then surged by 244.71% to $31.1 million in 2025, then tumbled by 53.25% to $14.5 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $14.5 million, $31.1 million, and $27.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison